サンプル依頼リスト カート
  • English
市場調査レポート
商品コード
1206468

アジア太平洋地域の左心室補助装置市場の2028年までの予測- 地域別分析- 流れの種類別、デザイン別、用途別

Asia Pacific Left Ventricular Assist Device Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - Type of Flow, Design, and Application
出版日: | 発行: The Insight Partners | ページ情報: 英文 111 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
アジア太平洋地域の左心室補助装置市場の2028年までの予測- 地域別分析- 流れの種類別、デザイン別、用途別
出版日: 2023年01月20日
発行: The Insight Partners
ページ情報: 英文 111 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

アジア太平洋地域の左心室補助装置市場は、2022年の2億6,301万米ドルから2028年には3億7,099万米ドルに成長すると予測されます。2022年から2028年までのCAGRは5.9%と推定されます。

新興国における未開発のポテンシャルが、アジア太平洋地域の左心室補助装置市場の成長を今後牽引する

インドや中国などの新興国は、患者数の増加、研究開発活動の活発化、CVDに対する意識の高まり、可処分所得の急増、医療インフラの改善、先進国に比べて比較的寛大な政策などにより、左心室補助装置市場のプレーヤーに大きな成長機会を提供すると期待されます。また、これらの新興市場では、過去10年間にわたり心不全患者が増加し続けています。新興国における高い成長機会を活用するため、メーカーはこれらの国々での事業拡大のために、研究開発などの戦略的な活動を取り入れています。世界銀行によると、中国とインドの医療費は、2018年から2019年にかけてそれぞれ5.35％、3.01％増加しました。インドブランド・エクイティ財団によると、インドのヘルスケア部門はCAGR17%で繁栄しており、2020年には2,800億米ドルの規模になり、病院が収益の～71%を占めています。中国では、2011年から2017年にかけて、民間病院の数が倍増して16,900に達しました。私立病院は、国内の病院全体の～57.2％を占めています。したがって、新興経済諸国におけるヘルスケア施設の進歩は、病院数の急増とともに、アジア太平洋地域の左心室補助装置市場における新興経済諸国でのLVADの採用を促進すると考えられます。

アジア太平洋地域の左心室補助装置市場の概要

アジア太平洋地域の左心室補助装置市場は、中国、日本、インド、韓国、オーストラリア、その他アジア太平洋地域に区分されます。この地域の市場成長は、高齢者人口の増加、心不全患者の増加、心血管疾患有病率の急上昇、LVAD関連費用の保険適用に起因しています。中国の急速な社会経済的進歩や変化は、人々のライフスタイルに影響を与え、その結果、心血管疾患のリスクを増大させています。BioMed Central（BMC）に掲載された論文によると、CVDは中国における死亡の40％以上に寄与しています。また、2019年には、中国で～1億2,033万人がCVDに罹患しています。CVDはさらに心不全につながるため、CVDの症例の増加は、中国におけるLVADの需要を煽る。

アジア太平洋地域の左心室補助装置市場の収益と2028年までの予測

アジア太平洋地域の左心室補助装置市場のセグメンテーション

アジア太平洋地域の左心室補助装置市場は、流れのタイプ、デザイン、用途、国ごとに区分されます。

左心室補助装置市場は、流れのタイプによって、非脈動性と脈動性に分けられます。2022年には、非脈動性セグメントが最大の市場シェアを記録しました。

デザインに基づき、アジア太平洋地域の左心室補助装置市場は、植え込み型心室補助装置と経皮的心室補助装置に二分されます。2022年には植え込み型補助人工心臓が最大の市場シェアを記録しました。

用途別に見ると、アジア太平洋地域の左心室補助装置市場は、目的地治療、移植への橋渡し、候補地への橋渡し、回復への橋渡しに分類されます。2022年に最大の市場シェアを獲得したのは、目的地治療分野です。

アジア太平洋地域の左心室補助装置市場は、国別に、中国、日本、インド、オーストラリア、韓国、その他アジア太平洋地域に区分されます。2022年は中国が市場を席巻しています。

ABIOMED Inc、Abbott Laboratories、Medtronic Plc、LivaNova Plc、Terumo Corp、BiVACOR Inc、Evaheart Inc、BioVentrix Incは、アジア太平洋地域の左心室補助装置市場で事業を展開している主要企業です。

目次

第1章 イントロダクション

第2章 重要なポイント

第3章 調査手法

  • カバレッジ
  • 2次調査
  • 1次調査

第4章 アジア太平洋地域の左心室補助装置市場- 市場展望

  • PEST分析
  • 専門家の見解

第5章 アジア太平洋地域の左心室補助装置市場- 主な市場力学

  • 市場促進要因
    • 対象疾患と手術の発生率の上昇
  • 市場抑制要因
    • 左心室補助装置に関する製品回収と合併症の増加
  • 市場機会
    • 新興国における未開発のポテンシャル
  • 今後の動向
    • LVADにおける人工知能と機械学習の利用拡大
  • 影響度分析

第6章 アジア太平洋地域の左心室補助装置市場分析

  • アジア太平洋地域の左心室補助装置市場の収益と予測・分析

第7章 アジア太平洋地域の左心室補助装置市場分析- 流れの種類別

  • アジア太平洋地域の左心室補助装置市場、流れの種類別2021年・2028年（%）
  • 拍動性フロー
  • 非脈動性

第8章 アジア太平洋地域の左心室補助装置の市場分析- デザイン別

  • アジア太平洋地域の左心室補助装置市場：デザイン別2021年 &2028年（%）
  • 植え込み型心室補助装置
  • 経皮型心室補助装置

第9章 アジア太平洋地域の左心室補助装置市場分析- 用途別

  • アジア太平洋地域の左心室補助装置市場：用途別、2021年・2028年（%）
  • 移植への橋渡し
  • デスティネーションセラピー
  • 回復への橋渡し
  • 候補への橋渡し

第10章 アジア太平洋地域の左心室補助装置市場- 国別分析

    • アジア太平洋地域
      • 中国
      • 日本
      • インド
      • 韓国
      • オーストラリア
      • その他アジア太平洋地域

第11章 企業プロファイル

  • ABIOMED Inc
  • Abbott Laboratories
  • Medtronic Plc
  • LivaNova Plc
  • Terumo Corp
  • BiVACOR Inc
  • BioVentrix Inc

第12章 付録

図表

List Of Tables

  • Table 1. China Left Ventricular Assist Device Market, by Type of Flow - Revenue and Forecast to 2028 (US$ Million)
  • Table 2. China Left Ventricular Assist Device Market, by Design - Revenue and Forecast to 2028 (US$ Million)
  • Table 3. China Left Ventricular Assist Device Market, by Application - Revenue and Forecast to 2028 (US$ Million)
  • Table 4. Japan Left Ventricular Assist Device Market, by Type of Flow - Revenue and Forecast to 2028 (US$ Million)
  • Table 5. Japan Left Ventricular Assist Device Market, by Design - Revenue and Forecast to 2028 (US$ Million)
  • Table 6. Japan Left Ventricular Assist Device Market, by Application - Revenue and Forecast to 2028 (US$ Million)
  • Table 7. India Left Ventricular Assist Device Market, by Type of Flow - Revenue and Forecast to 2028 (US$ Million)
  • Table 8. India Left Ventricular Assist Device Market, by Design - Revenue and Forecast to 2028 (US$ Million)
  • Table 9. India Left Ventricular Assist Device Market, by Application - Revenue and Forecast to 2028 (US$ Million)
  • Table 10. South Korea Left Ventricular Assist Device Market, by Type of Flow - Revenue and Forecast to 2028 (US$ Million)
  • Table 11. South Korea Left Ventricular Assist Device Market, by Design - Revenue and Forecast to 2028 (US$ Million)
  • Table 12. South Korea Left Ventricular Assist Device Market, by Application - Revenue and Forecast to 2028 (US$ Million)
  • Table 13. Australia Left Ventricular Assist Device Market, by Type of Flow - Revenue and Forecast to 2028 (US$ Million)
  • Table 14. Australia Left Ventricular Assist Device Market, by Design - Revenue and Forecast to 2028 (US$ Million)
  • Table 15. Australia Left Ventricular Assist Device Market, by Application - Revenue and Forecast to 2028 (US$ Million)
  • Table 16. Rest of Asia Pacific Left Ventricular Assist Device Market, by Type of Flow - Revenue and Forecast to 2028 (US$ Million)
  • Table 17. Rest of Asia Pacific Left Ventricular Assist Device Market, by Design - Revenue and Forecast to 2028 (US$ Million)
  • Table 18. Rest of Asia Pacific Left Ventricular Assist Device Market, by Application - Revenue and Forecast to 2028 (US$ Million)
  • Table 19. Glossary of Terms

List Of Figures

  • Figure 1. Asia Pacific Left Ventricular Assist Device Market Segmentation
  • Figure 2. Asia Pacific Left Ventricular Assist Device Market, By Country
  • Figure 3. Asia Pacific Left Ventricular Assist Device Market Overview
  • Figure 4. Implantable Ventricular Assist Device Held Largest Share for Design Segment in Left Ventricular Assist Device Market
  • Figure 5. China is Expected to Show Remarkable Growth During the Forecast Period
  • Figure 6. Asia Pacific: PEST Analysis
  • Figure 7. Experts Opinion
  • Figure 8. Impact Analysis
  • Figure 9. Asia Pacific Left Ventricular Assist Device Market - Revenue Forecast and Analysis - 2020- 2028
  • Figure 10. Asia Pacific Left Ventricular Assist Device Market, by Type of Flow 2021 & 2028 (%)
  • Figure 11. Pulsatile Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 12. Non-Pulsatile Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 13. Asia Pacific Left Ventricular Assist Device Market, by Design 2021 & 2028 (%)
  • Figure 14. Implantable Ventricular Assist Devices Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 15. Transcutaneous Ventricular Assist Devices Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 16. Asia Pacific Left Ventricular Assist Device Market, by Application 2021 & 2028 (%)
  • Figure 17. Bridge to Transplantation Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 18. Destination Therapy Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 19. Bridge to Recovery Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 20. Bridge to Candidacy Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 21. Asia Pacific: Left Ventricular Assist Device Market, by Key Country - Revenue (2021) (US$ Million)
  • Figure 22. China: Left Ventricular Assist Device Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 23. Japan: Left Ventricular Assist Device Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 24. India: Left Ventricular Assist Device Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 25. South Korea: Left Ventricular Assist Device Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 26. Australia: Left Ventricular Assist Device Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 27. Rest of Asia Pacific: Left Ventricular Assist Device Market - Revenue and Forecast to 2028 (US$ Million)
目次
Product Code: BMIRE00027901

The Asia Pacific left ventricular assist device market is expected to grow from US$ 263.01 million in 2022 to US$ 370.99 million by 2028. It is estimated to register a CAGR of 5.9% from 2022 to 2028.

Untapped Potential in Emerging Economies to Drive Asia Pacific Left Ventricular Assist Device Market Growth in Coming Years

Emerging countries such as India and China are expected to offer significant growth opportunities to the left ventricular assist device market players mainly due to the rising patient population, increasing R&D activities, growing CVD awareness, surging disposable incomes, improving healthcare infrastructure, and comparatively lenient policies compared to developed countries. These emerging markets have also seen a sustained increase in heart failure cases over the past decade. To capitalize on high growth opportunities prevailing in emerging markets, manufacturers are adopting strategic activities such as R&D for business expansion in these countries. According to the World Bank, health spending in China and India, increased by 5.35% and 3.01%, respectively, from 2018 to 2019. According to the India Brand Equity Foundation, the healthcare sector in India has flourished at a CAGR of 17%; it was worth US$ 280 billion in 2020, with hospitals accounting for ~71% of revenue. In China, the number of private hospitals has doubled to reach 16,900 during 2011-2017. Private hospitals account for ~57.2% of total hospitals in the country. Therefore, advancements in healthcare facilities in developing economies, along with a surge in the number of hospitals, are likely to drive the adoption of LVADs in emerging economies in the Asia Pacific left ventricular assist device market.

Asia Pacific Left Ventricular Assist Device Market Overview

The Asia Pacific left ventricular assist device market is segmented into China, Japan, India, South Korea, Australia, South Korea, and the Rest of Asia Pacific. The market growth in this region is attributed to the rising geriatric population, increasing heart failure cases, surging cardiovascular disease prevalence, and inclusion of LVAD-associated costs in insurance coverage. Rapid socioeconomic progress and changes in China are affecting the lifestyle of populations, which in turn, increases the risk of cardiovascular diseases. According to an article published in BioMed Central (BMC), CVDs contribute to more than 40% of deaths in China. In addition, in 2019, ~120.33 million people suffered from CVDs in China. CVD further leads to heart failure; therefore, the increase in cases of CVDs fuels the demand for LVADs in China.

Asia Pacific Left Ventricular Assist Device Market Revenue and Forecast to 2028 (US$ Million)

Asia Pacific Left Ventricular Assist Device Market Segmentation

The Asia Pacific left ventricular assist device market is segmented into type of flow, design, application, and country.

Based on type of flow, the Asia Pacific left ventricular assist device market is segmented into non-pulsatile and pulsatile flow . The non-pulsatile segment registered the largest market share in 2022.

Based on design, the Asia Pacific left ventricular assist device market is bifurcated into implantable ventricular assist devices and transcutaneous ventricular assist devices . The implantable ventricular assist devices segment registered the largest market share in 2022.

Based on application, the Asia Pacific left ventricular assist device market is segmented into destination therapy, bridge to transplantation, bridge to candidacy, and bridge to recovery . The destination therapy segment registered the largest market share in 2022

The Asia Pacific left ventricular assist device market, based on country, is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the market in 2022.

ABIOMED Inc; Abbott Laboratories; Medtronic Plc; LivaNova Plc; Terumo Corp; BiVACOR Inc; Evaheart Inc; and BioVentrix Inc are the leading companies operating in the Asia Pacific left ventricular assist device market.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Asia Pacific left ventricular assist device market.
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific left ventricular assist device market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the left ventricular assist device market, as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Asia Pacific Left Ventricular Assist Device Market - By Type of Flow
    • 1.3.2 Asia Pacific Left Ventricular Assist Device Market - By Design
    • 1.3.3 Asia Pacific Left Ventricular Assist Device Market - By Application
    • 1.3.4 Asia Pacific Left Ventricular Assist Device Market - By Country

2. Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Asia Pacific Left Ventricular Assist Device Market - Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
  • 4.3 Experts Opinion

5. Asia Pacific Left Ventricular Assist Device Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Elevating Incidence of Target Diseases and Procedures
  • 5.2 Market Restraints
    • 5.2.1 Rise in Product Recalls and Complications Associated with Left Ventricular Assist Devices
  • 5.3 Market Opportunities
    • 5.3.1 Untapped Potential of Emerging Economies
  • 5.4 Future Trends
    • 5.4.1 Widening Use of Artificial Intelligence and Machine Learning in LVAD
  • 5.5 Impact Analysis

6. Asia Pacific Left Ventricular Assist Device Market Analysis

  • 6.1 Asia Pacific Left Ventricular Assist Device Market Revenue Forecast & Analysis

7. Asia Pacific Left Ventricular Assist Device Market Analysis - By Type of Flow

  • 7.1 Overview
  • 7.2 Asia Pacific Left Ventricular Assist Device Market, By Type of Flow 2021 & 2028 (%)
  • 7.3 Pulsatile Flow
    • 7.3.1 Overview
    • 7.3.2 Pulsatile Market Revenue and Forecast to 2028 (US$ Million)
  • 7.4 Non-Pulsatile
    • 7.4.1 Overview
    • 7.4.2 Non-Pulsatile Market Revenue and Forecast to 2028 (US$ Million)

8. Asia Pacific Left Ventricular Assist Device Market Analysis - by Design

  • 8.1 Overview
  • 8.2 Asia Pacific Left Ventricular Assist Device Market, By Design 2021 & 2028 (%)
  • 8.3 Implantable Ventricular Assist Devices
    • 8.3.1 Overview
    • 8.3.2 Implantable Ventricular Assist Devices Market Revenue and Forecast to 2028 (US$ Million)
  • 8.4 Transcutaneous Ventricular Assist Devices
    • 8.4.1 Overview
    • 8.4.2 Transcutaneous Ventricular Assist Devices Market Revenue and Forecast to 2028 (US$ Million)

9. Asia Pacific Left Ventricular Assist Device Market - By Application

  • 9.1 Overview
  • 9.2 Asia Pacific Left Ventricular Assist Device Market, By Application 2021 & 2028 (%)
  • 9.3 Bridge to Transplantation
    • 9.3.1 Overview
    • 9.3.2 Bridge to Transplantation Market Revenue and Forecast to 2028 (US$ Million)
  • 9.4 Destination Therapy
    • 9.4.1 Overview
    • 9.4.2 Destination Therapy Market Revenue and Forecast to 2028 (US$ Million)
  • 9.5 Bridge to Recovery
    • 9.5.1 Overview
    • 9.5.2 Bridge to Recovery Market Revenue and Forecast to 2028 (US$ Million)
  • 9.6 Bridge to Candidacy
    • 9.6.1 Overview
    • 9.6.2 Bridge to Candidacy Market Revenue and Forecast to 2028 (US$ Million)

10. Asia Pacific Left Ventricular Assist Device Market - Country Analysis

  • 10.1 Overview
    • 10.1.1 Asia Pacific: Left Ventricular Assist Device Market, by Country, 2021 & 2028 (%)
      • 10.1.1.1 China: Left Ventricular Assist Device Market - Revenue and Forecast to 2028 (USD Million)
        • 10.1.1.1.1 Overview
        • 10.1.1.1.2 China: Left Ventricular Assist Device Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.1.3 China: Left Ventricular Assist Device Market, by Type of Flow, 2019-2028 (US$ Million)
        • 10.1.1.1.4 China: Left Ventricular Assist Device Market, by Design, 2019-2028 (US$ Million)
        • 10.1.1.1.5 China Left Ventricular Assist Device Market, by Application, 2019-2028 (USD Million)
      • 10.1.1.2 Japan: Left Ventricular Assist Device Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.2.1 Overview
        • 10.1.1.2.2 Japan: Left Ventricular Assist Device Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.2.3 Japan: Left Ventricular Assist Device Market, by Type of Flow, 2019-2028 (US$ Million)
        • 10.1.1.2.4 Japan: Left Ventricular Assist Device Market, by Design, 2019-2028 (US$ Million)
        • 10.1.1.2.5 Japan: Left Ventricular Assist Device Market, by Application, 2019-2028 (US$ Million)
      • 10.1.1.3 India: Left Ventricular Assist Device Market - Revenue and Forecast to 2028 (USD Million)
        • 10.1.1.3.1 Overview
        • 10.1.1.3.2 India: Left Ventricular Assist Device Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.3.3 India: Left Ventricular Assist Device Market, by Type of Flow, 2019-2028 (US$ Million)
        • 10.1.1.3.4 India: Left Ventricular Assist Device Market, by Design, 2019-2028 (US$ Million)
        • 10.1.1.3.5 India: Left Ventricular Assist Device Market, by Application, 2019-2028 (US$ Million)
      • 10.1.1.4 South Korea: Left Ventricular Assist Device Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.4.1 Overview
        • 10.1.1.4.2 South Korea: Left Ventricular Assist Device Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.4.3 South Korea: Left Ventricular Assist Device Market, by Type of Flow, 2019-2028 (US$ Million)
        • 10.1.1.4.4 South Korea: Left Ventricular Assist Device Market, by Design, 2019-2028 (US$ Million)
        • 10.1.1.4.5 South Korea: Left Ventricular Assist Device Market, by Application, 2019-2028 (US$ Million)
      • 10.1.1.5 Australia: Left Ventricular Assist Device Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.5.1 Overview
        • 10.1.1.5.2 Australia: Left Ventricular Assist Device Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.5.3 Australia: Left Ventricular Assist Device Market, by Type of Flow, 2019-2028 (US$ Million)
        • 10.1.1.5.4 Australia: Left Ventricular Assist Device Market, by Design, 2019-2028 (US$ Million)
        • 10.1.1.5.5 Australia: Left Ventricular Assist Device Market, by Application, 2019-2028 (US$ Million)
      • 10.1.1.6 Rest of Asia Pacific: Left Ventricular Assist Device Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.6.1 Overview
        • 10.1.1.6.2 Rest of Asia Pacific: Left Ventricular Assist Device Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.6.3 Rest of Asia Pacific: Left Ventricular Assist Device Market, by Type of Flow, 2019-2028 (US$ Million)
        • 10.1.1.6.4 Rest of Asia Pacific: Left Ventricular Assist Device Market, by Design, 2019-2028 (US$ Million)
        • 10.1.1.6.5 Rest of Asia Pacific: Left Ventricular Assist Device Market, by Application, 2019-2028 (US$ Million)

11. Company Profiles

  • 11.1 ABIOMED Inc
    • 11.1.1 Key Facts
    • 11.1.2 Business Description
    • 11.1.3 Products and Services
    • 11.1.4 Financial Overview
    • 11.1.5 SWOT Analysis
    • 11.1.6 Key Developments
  • 11.2 Abbott Laboratories
    • 11.2.1 Key Facts
    • 11.2.2 Business Description
    • 11.2.3 Products and Services
    • 11.2.4 Financial Overview
    • 11.2.5 SWOT Analysis
    • 11.2.6 Key Developments
  • 11.3 Medtronic Plc
    • 11.3.1 Key Facts
    • 11.3.2 Business Description
    • 11.3.3 Products and Services
    • 11.3.4 Financial Overview
    • 11.3.5 SWOT Analysis
    • 11.3.6 Key Developments
  • 11.4 LivaNova Plc
    • 11.4.1 Key Facts
    • 11.4.2 Business Description
    • 11.4.3 Products and Services
    • 11.4.4 Financial Overview
    • 11.4.5 SWOT Analysis
    • 11.4.6 Key Developments
  • 11.5 Terumo Corp
    • 11.5.1 Key Facts
    • 11.5.2 Business Description
    • 11.5.3 Products and Services
    • 11.5.4 Financial Overview
    • 11.5.5 SWOT Analysis
    • 11.5.6 Key Developments
  • 11.6 BiVACOR Inc
    • 11.6.1 Key Facts
    • 11.6.2 Business Description
    • 11.6.3 Products and Services
    • 11.6.4 Financial Overview
    • 11.6.5 SWOT Analysis
    • 11.6.6 Key Developments
  • 11.7 BioVentrix Inc
    • 11.7.1 Key Facts
    • 11.7.2 Business Description
    • 11.7.3 Products and Services
    • 11.7.4 Financial Overview
    • 11.7.5 SWOT Analysis
    • 11.7.6 Key Developments

12. Appendix

  • 12.1 About The Insight Partners
  • 12.2 Glossary of Terms